142 related articles for article (PubMed ID: 15615644)
1. Can tau filaments be both physiologically beneficial and toxic?
King ME
Biochim Biophys Acta; 2005 Jan; 1739(2-3):260-7. PubMed ID: 15615644
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
5. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
[TBL] [Abstract][Full Text] [Related]
6. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
Navarrete LP; Pérez P; Morales I; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
[TBL] [Abstract][Full Text] [Related]
7. Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.
Obulesu M; Venu R; Somashekhar R
Neurochem Res; 2011 Aug; 36(8):1329-35. PubMed ID: 21509508
[TBL] [Abstract][Full Text] [Related]
8. Granular tau oligomers as intermediates of tau filaments.
Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
[TBL] [Abstract][Full Text] [Related]
9. Role of tau protein in Alzheimer's disease: The prime pathological player.
Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
[TBL] [Abstract][Full Text] [Related]
10. Abnormal tau-containing filaments in neurodegenerative diseases.
Crowther RA; Goedert M
J Struct Biol; 2000 Jun; 130(2-3):271-9. PubMed ID: 10940231
[TBL] [Abstract][Full Text] [Related]
11. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
12. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
13. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
14. Tau oligomers and aggregation in Alzheimer's disease.
Meraz-Ríos MA; Lira-De León KI; Campos-Peña V; De Anda-Hernández MA; Mena-López R
J Neurochem; 2010 Mar; 112(6):1353-67. PubMed ID: 19943854
[TBL] [Abstract][Full Text] [Related]
15. Is tau aggregation toxic or protective?
Congdon EE; Duff KE
J Alzheimers Dis; 2008 Aug; 14(4):453-7. PubMed ID: 18688098
[TBL] [Abstract][Full Text] [Related]
16. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
17. Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles.
Qureshi HY; Li T; MacDonald R; Cho CM; Leclerc N; Paudel HK
Biochemistry; 2013 Sep; 52(37):6445-55. PubMed ID: 23962087
[TBL] [Abstract][Full Text] [Related]
18. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
Huang HC; Jiang ZF
J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
[TBL] [Abstract][Full Text] [Related]
19. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
20. Isoaspartate formation and neurodegeneration in Alzheimer's disease.
Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T
Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
